×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

3047£¡×ðÁú¿­Ê±½«ÔÚAACR չʾ¶àÖÖзÖ×ÓÆ½Ì¨

2023-04-12
|
»á¼ûÁ¿£º

3047£¡×ðÁú¿­Ê±½«ÔÚAACR-չʾ¶àÖÖзÖ×ÓÆ½Ì¨.jpg

×ðÁú¿­Ê±¼´½«¼ÓÈë2023ÄêÃÀ¹ú°©Ö¢Ñо¿Ð­»áÄê»á(American Association for Cancer Research Annual Meeting, AACRÄê»á)¡£±¾½ìÄê»á½«º­¸ÇÐí¶àÈÈÃÅ»°Ìâ £¬°üÀ¨ÃâÒßÖÎÁÆ¡¢»ùÒò±à¼­¡¢Ò©ÎïÑо¿ºÍÁÙ´²ÊÔÑéµÈÁìÓòµÄ×îÐÂÏ£ÍûºÍÇ÷ÊÆ¡£×ðÁú¿­Ê±Ò©ÀíҩЧÓëÉúÎﲿ¸±×ܲõ˾²²©Ê¿Óë×ðÁú¿­Ê±¹ú¼ÊÑз¢Ð§ÀͲ¿Ö´Ðи±×ܲô÷ѧ¶«²©Ê¿½«Ð­Í¬×ðÁú¿­Ê±ÃÀ¹úÍŶÓһͬÁÁÏàAACRÄê»áÏÖ³¡(Orange County Convention Center, Orlando, FL) £¬ÌṩЧÀÍչʾºÍ½»Á÷ʱ»ú £¬×ðÁú¿­Ê±Õ¹Î»ºÅ3047 £¬ÆÚ´ýÓëÄúµÄÎîÃæ£¡

ʱ¼ä | 4.14-4.19, 2023

µØµã | ·ðÂÞÀï´ïÖݰÂÀ¼¶à°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ

×ðÁú¿­Ê±Õ¹Î»ºÅ | #3047

AACRÏÈÈÝ

ÃÀ¹ú°©Ö¢Ñо¿Ð­»á(AACR)ÊǵÚÒ»¸öÒ²ÊÇ×î´óµÄÖÂÁ¦ÓÚ¼ÓËÙÕ÷·þ°©Ö¢µÄ°©Ö¢Ñо¿×éÖ¯¡£AACRÓÚ1907Äê5ÔÂ7ÈÕÔÚ»ªÊ¢¶ÙÌØÇø½¨Éè £¬ÓÉ11Ãû¶ÔÑо¿¸ÐÐËȤµÄÒ½ÉúºÍ¿ÆÑ§¼Ò×é³É £¬Ö¼ÔÚ¡°½øÒ»³ÌÐò²éºÍÈö²¥°©Ö¢ÖªÊ¶¡±¡£2023 AACRÄê»áÖ÷Ì⣺Advancing the Frontiers of Cancer Science and Medicine£¨Íƽø°©Ö¢¿ÆÑ§ºÍҽѧµÄÇ°ÑØ£©¡£

ÿÄêAACRÄê»áÉ϶¼»áÐû²¼°©Ö¢ÖÎÁÆ×îÐÂÏ£Íû¡£½ñÄ꽫ÔÚ·ðÂÞÀï´ïÖݰÂÀ¼¶àµÄ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ(4ÔÂ16ÈÕÖÁ19ÈÕÕ¹³ö)ÓëÀ´×ÔÌìϸ÷µØµÄ2Íò¶àÃû¿ÆÑ§¼ÒºÍÆäËû°©Ö¢×¨ÒµÈËÊ¿ÅöÃæ¡£ÕâЩÓë»áÕßÊÇʵÑéÊÒ¿ÆÑ§¼ÒºÍÁÙ´²Ñо¿Ö°Ô± £¬ËûÃÇרעÓÚ°©Ö¢Ñо¿µÄ¸÷¸ö·½Ãæ £¬°üÀ¨ÊµÑéÖÎÁÆÑ§¡¢·Ö×Ó°ÐÏòÖÎÁÆ¡¢»¯Ñ§¡¢·Ö×ÓÉúÎïѧºÍÒÅ´«Ñ§¡¢ÃâÒßѧºÍÃâÒßÖÎÁÆ¡¢Ö×ÁöÉúÎïѧ¡¢²¡¶¾Ñ§¡¢¶¾Àíѧ¡¢Ô¤·ÀÒÔ¼°ÁÙ´²ºÍת»¯Ñо¿¡£

×ðÁú¿­Ê±Õ¹Î»

×ðÁú¿­Ê±AACRչλ.jpg

AACRÕ¹ÌüλÓÚ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄÎ÷Â¥2²ãµÄB¹ÝºÍD¹Ý £¬×ðÁú¿­Ê±Õ¹Ì¨Î»ÓÚ×¢²ą́Èë¿Ú´¦ £¬Õ¹Î»ºÅ3047¡£

×ðÁú¿­Ê±Poster

´Ë´ÎAACR¾Û»áÉÏ×ðÁú¿­Ê±´øÀ´2Õź£±¨ £¬Õ¹Ê¾×ðÁú¿­Ê±ADCºÍPROTACƽ̨µÄǿʢʵÁ¦£º"Evaluation of The Efficacy of ADC Drugs In Vitro & Vivo" ºÍ "Efficacy Studies and PK/PD of PROTAC Drugs In Vitro &Vivo"

×ðÁú¿­Ê±ÔÚADCµÄÁÙ´²Ç°Ò»Ì廯Ñо¿¼Æ»®Öƶ©ÖÐÓë¿Í»§ÉîÈë½»Á÷ £¬¿ÆÑÐÖ÷¸É½«Ã¿Ò»¸ö°¸ÀýµÄÌØµãÓë¶àÄêʵսÂÄÀúºÍÊÖÒÕ»ýÀÛÏàÁ¬Ïµ £¬ÉóÉ÷µØ½«ÓÅÖÊʵÑ鼯»®ÓëЧ¹ûÌá½»µ½¿Í»§ÊÖÉÏ¡£×ðÁú¿­Ê±¿ÉÒÔΪ¿Í»§ÌṩADC Payloads ºÏ³É¡¢ADC ҩЧѧÆÀ¼Û¡¢ADC Ò©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍADC Çå¾²ÐÔÆÀ¼ÛµÈЧÀÍ¡£×èÖ¹2022Äêβ £¬×ðÁú¿­Ê±ÒÑÀÖ³ÉÖúÁ¦13¸öADCÒ©Îï»ñÅúÁÙ´² £¬²¢ÓÐ10¶à¸öADCÏîÄ¿ÔÚÑС£×èÖ¹ÏÖÔÚ £¬×ðÁú¿­Ê±³Ð½ÓµÄINDÉ걨ÀàÉúÎïÒ©´óÏîÄ¿ÒѾ­100¶àÏî £¬°üÀ¨µ¥¿¹¡¢Ë«¿¹¡¢¶à¿¹¡¢ADC¡¢²¡¶¾ÒßÃçºÍÈÚºÏÂѰ׵È¡£

×ðÁú¿­Ê±PROTACÒ©Îï·¢Ã÷ÊÖÒÕÆ½Ì¨»ã×ÜÁËÄ¿½ñÊ¢ÐеÄÈÈÃŵİбêÂѰ×ÅäÌå £»½¨ÉèÁËÆÕ±éµÄÈÈÃŰÐÏòÂѰ׸߶ÈÇ׺ÍÁ¦Ð¡·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï»¯ºÏÎï¿â£¨TPSM£© £¬ÆÕ±éµÄE3ÅþÁ¬Ã¸ £¬¸ß¶ÈÇ׺ÍÁ¦µÄС·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï£¨E3SM£© £»½¨ÉèÁËlinkerϵͳ,°üÀ¨ÍøÂç´ó×Ú¾ßÓÐÆÕ±é¶àÑùÐÔµÄË«¹ÙÄÜÍÅÅþÁ¬Ì壨BF-Linker£©¡£ÕâЩ»ýÀ۵ϝºÏÎï¿â¿ÉÒÔ×ÊÖú¿ìËÙ¸ßЧµÄºÏ³É´ó×ڸ߻îÐÔPROTACË«ÌØÒìÐÔС·Ö×Ó £¬¼«´óµØÌá¸ß½ÓÄÉPROTACÊÖÒÕ¾ÙÐеÄÒ©ÎïÑз¢Àú³Ì¡£³ýÁË¿ìËٺϳÉÖ®Íâ £¬ÎÒÃÇͬʱ½¨ÉèºÍÍêÉÆµÄPROTACÉúÎïɸѡÓë²âÊÔÆ½Ì¨ £¬ºóÐøÉú³¤¹âÁÙ´²Ç°ËùÓн׶Ρ£×èÖ¹2022Äêβ £¬×ðÁú¿­Ê±ÒÑÀÖ³ÉÖúÁ¦3¸öPROTACÒ©Îï»ñÅúÁÙ´² £¬²¢ÓÐ20¶à¸öPROTACÏîÄ¿ÔÚÑС£

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿